Physician

Jennifer L Muller, MD

According to 2025 Medicare claims, Jennifer Muller, MD (NPI: 1790763985) practices medical oncology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34105-5020.

Muller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,341 traditional Medicare patients, billed 322,932 HCPCS/CPT codes, and received $4,610,214 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,459 prescription claims across 296 beneficiaries totaling $2,891,296 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 38 claims. Open Payments data shows 147 records totaling $3,262. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $52,175 to $4,610,214. Similarly, Part D prescription costs have risen steadily, from $550,039 to $2,891,296. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	300	837	$52,175
2016	338	836	$48,708
2017	320	708	$41,794
2018	338	751	$45,890
2019	341	640	$40,630
2020	648	68,006	$545,028
2021	997	192,823	$1,637,188
2022	1,011	215,762	$2,290,272
2023	1,132	309,989	$3,832,058
2024	1,341	322,932	$4,610,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	137	729	$550,039
2016	149	944	$690,486
2017	139	979	$407,375
2018	166	1,132	$640,240
2019	261	1,064	$1,067,336
2020	216	689	$665,968
2021	147	807	$1,179,443
2022	188	968	$976,732
2023	243	1,114	$1,823,281
2024	296	1,459	$2,891,296

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	17	$1,744
2017	N/R	36	$2,356
2018	13	42	$2,900
2019	15	21	$2,275
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	38	$5,066
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	446	1,029	$97
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	143	196	$13
96372	Injection of drug or substance under skin or into muscle	353	1,245	$11
36415	Insertion of needle into vein for collection of blood sample	973	2,617	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	921	2,616	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	33	924	$527,886
Imbruvica	Ibrutinib	22	640	$278,732
Xtandi	Enzalutamide	19	570	$268,732
Pomalyst	Pomalidomide	11	308	$239,773
Talzenna	Talazoparib Tosylate	13	390	$233,889

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	147	$3,262	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer L. Muller, MD?

Tedicare shows public-source Medicare data for Jennifer L. Muller, MD (NPI 1790763985), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer L. Muller, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jennifer L. Muller, MD?

Jennifer L. Muller, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Jennifer L. Muller, MD have Open Payments data?

Jennifer L. Muller, MD has 147 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.